By Brent Potter, PhD — I am grateful to be alive during to see the apex and decline of evidence-based psychotherapy and psychiatry. Honestly, I didn’t think that I’d see anything like it in my lifetime. It was looking pretty daunting for a while, but we’re not only making substantial progress, but winning. — Please don’t mistake me—we have plenty more to do. We’re not in the clear yet, but we’re light years ahead of where we were roughly 20 years ago. … [click on title for the rest of the post]
Psychiatry Under the Influence investigates how the influence of pharmaceutical money and guild interests has corrupted the behavior of the American Psychiatric Association and academic psychiatry during the past 35 years. … [click on the title to read and view more]
Influential “thought leader” psychiatrists and major psychiatry institutions, by their own recent admissions, have been repeatedly wrong about illness/disorder validity, biochemical causes, and drug treatments; and also, in several cases, have been discovered to be on the take from drug companies—yet continue to be taken seriously by the mainstream media.
While Big Pharma financial backing is one reason that psychiatry is able to retain its clout, this is not the only reason. More insidiously, psychiatry retains influence because of the needs of the larger power structure that rules us. And perhaps most troubling, psychiatry retains influence because of us—and our increasing fears that have resulted in our expanding needs for coercion. … [click on title for the rest of the post]
Mental health advocate Leah Harris speaks at MindFreedom’s 2014 annual protest of the American Psychiatric Association in NYC. … [click on title for the rest of the post]
Western psychiatry is in crisis. The direction taken by the new Diagnostic and Statistical Manual of Mental Disorders (DSM 5), due to be published later this week, has received ample criticism. Moreover, in disagreement with the American Psychiatric Association, the United States National Institute of Mental Health (NIMH), the world’s largest research institute, has announced they will no longer fund projects based exclusively on DSM categories. Unfortunately, while Mental Health Europe considers the NIMH decision to be the right one, by focusing almost entirely on neuroscience and on so-called disorders of the brain, the NIMH is missing out on the critical importance of user experiences to psychiatric research and to the practice of psychiatry. … [click on title for the rest of the post]
My friend and co-editor here on Beyond Meds, Will Hall, spoke at the American Psychiatric Association a day or two ago. I just listened to this talk and was moved very deeply. Imagine — he just said all this stuff in front of a room filled with psychiatrists!!